Stereotaxis Inc. 10.20.16
Stereotaxis Inc., a global developer of robotic technologies for the treatment of cardiac arrhythmias, announced that the State Intellectual Property Office of the People’s Republic of China has awarded a patent protecting the company’s Vdrive robotic navigation system with V-Loop variable loop catheter manipulator.
The patent is the second awarded to Stereotaxis in China for its Vdrive system and related disposable devices. The first patent covered the Company’s V-CAS and V-CAS Deflect catheter advancement systems, and its V-Sono ICE catheter manipulator, as well as all device interfaces and methods.
“We continue to generate strong growth in the Asia Pacific market, which improved procedure volume by 65 percent in the first half of 2016 over the same period last year and now comprises nearly 10 percent of our worldwide procedures,” said William C. Mills, Stereotaxis CEO. “The market in China represents significant potential for our remote, robotic technologies and this patent reflects the further expansion of our proprietary technology designed to achieve greater safety, single operator efficiencies and improved patient outcomes in cardiac ablations.”
Employed in conjunction with the Stereotaxis Niobe ES magnetic navigation system, the V-Loop system remotely controls the advancement, retraction, rotation, tip deflection and loop size of a compatible circular mapping catheter, which is used in more than 60,000 complex ablation procedures worldwide each year. Its design enables a single operator to remotely control both the ablation catheter and circular mapping catheter and to do so with greater stability and maneuverability of the circular mapping catheter, supporting improved procedure results.
Stereotaxis develops robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. More than 100 issued patents support the Stereotaxis platform. Stereotaxis' core Epoch Solution includes the Niobe ES remote magnetic navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems, and the Vdrive robotic navigation system and consumables. The company is based in St. Louis, Mo.
The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. The V-Sono ICE catheter manipulator, V-Loop variable loop catheter manipulator, and V-CAS catheter advancement system have received clearance in the United States, Canada, and the European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union.
The patent is the second awarded to Stereotaxis in China for its Vdrive system and related disposable devices. The first patent covered the Company’s V-CAS and V-CAS Deflect catheter advancement systems, and its V-Sono ICE catheter manipulator, as well as all device interfaces and methods.
“We continue to generate strong growth in the Asia Pacific market, which improved procedure volume by 65 percent in the first half of 2016 over the same period last year and now comprises nearly 10 percent of our worldwide procedures,” said William C. Mills, Stereotaxis CEO. “The market in China represents significant potential for our remote, robotic technologies and this patent reflects the further expansion of our proprietary technology designed to achieve greater safety, single operator efficiencies and improved patient outcomes in cardiac ablations.”
Employed in conjunction with the Stereotaxis Niobe ES magnetic navigation system, the V-Loop system remotely controls the advancement, retraction, rotation, tip deflection and loop size of a compatible circular mapping catheter, which is used in more than 60,000 complex ablation procedures worldwide each year. Its design enables a single operator to remotely control both the ablation catheter and circular mapping catheter and to do so with greater stability and maneuverability of the circular mapping catheter, supporting improved procedure results.
Stereotaxis develops robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. More than 100 issued patents support the Stereotaxis platform. Stereotaxis' core Epoch Solution includes the Niobe ES remote magnetic navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems, and the Vdrive robotic navigation system and consumables. The company is based in St. Louis, Mo.
The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. The V-Sono ICE catheter manipulator, V-Loop variable loop catheter manipulator, and V-CAS catheter advancement system have received clearance in the United States, Canada, and the European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union.